ADAP

Adaptimmune Therapeutics
ADAP

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ADAP was delisted on the 27th of October, 2025.

Back to rankings

45 hedge funds and large institutions have $380M invested in Adaptimmune Therapeutics in 2015 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$113M
2
+$80.9M
3
+$32.3M
4
FCMI
Foresite Capital Management II
California
+$32.2M
5
Capital World Investors
Capital World Investors
California
+$20M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$550K
27
$521K
28
$504K
29
$458K
30
$452K
31
$440K
32
$367K
33
$333K
34
$293K
35
$279K
36
$273K
37
$231K
38
$211K
39
$95K
40
$40K
41
$33K
42
$18K
43
$4.19K
44
$4K
45
$3K
1
2